E Villar

Summary

Affiliation: Hospices Civils de Lyon
Country: France

Publications

  1. ncbi Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial
    Emmanuel Villar
    Hospices Civils de Lyon, Department of Nephrology, Lyon Sud Hospital, Pierre Benite, France
    J Diabetes Complications 25:237-43. 2011
  2. ncbi [Diabetes and chronic kidney disease: lessons from renal epidemiology]
    Emmanuel Villar
    Service de Nephrologie, dialyse et transplantation rénale, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Nephrol Ther 6:585-90. 2010
  3. ncbi [The NEPHRODIAB2 randomized trial]
    E Villar
    , Centre Hospitalier Lyon Sud, ,
    Nephrologie 24:317-9. 2003
  4. ncbi A multicentre study of registration on renal transplantation waiting list of the elderly and patients with type 2 diabetes
    Emmanuel Villar
    Department of Nephrology, Dialysis and Transplantation, Lyon Sud Hospital, Claude Bernard University, 165 Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Nephrol Dial Transplant 19:207-14. 2004
  5. ncbi Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease
    E Villar
    Australia and New Zealand Dialysis and Transplant Registry, Woodville, South Australia, Australia
    Diabetologia 52:2536-41. 2009
  6. ncbi Effect of age, gender, and diabetes on excess death in end-stage renal failure
    Emmanuel Villar
    Department of Nephrology, Dialysis and Transplantation, Lyon Sud Hospital, Pierre Benite, Lyon, France
    J Am Soc Nephrol 18:2125-34. 2007
  7. ncbi Poor prognosis of heart transplant patients with end-stage renal failure
    Emmanuel Villar
    Department of Nephrology, Dialysis and Transplantation, Hospices Civils de Lyon, Lyon Sud Hospital, Claude Bernard University, France
    Nephrol Dial Transplant 22:1383-9. 2007
  8. ncbi [Specificities of the methodology of survival analysis in dialysis patients]
    Emmanuel Villar
    Service de Nephrologie, dialyse et transplantation rénale, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, 69495 Pierre Benite, France
    Nephrol Ther 4:553-61. 2008
  9. ncbi Multicenter study of the renal transplantation selection process: multivariate analysis
    E Villar
    Nephrology-Transplantation Unit, Lyon Sud Hospital, , France
    Transplant Proc 34:845-6. 2002
  10. ncbi The Impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders
    A Karamé
    Nephrology and Renal Transplantation, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre Benite, France
    Nephron Clin Pract 112:c268-75. 2009

Detail Information

Publications22

  1. ncbi Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial
    Emmanuel Villar
    Hospices Civils de Lyon, Department of Nephrology, Lyon Sud Hospital, Pierre Benite, France
    J Diabetes Complications 25:237-43. 2011
    ..The NEPHRODIAB2 study was designed to assess efficacy and safety of complete hemoglobin (Hb) normalization in these patients...
  2. ncbi [Diabetes and chronic kidney disease: lessons from renal epidemiology]
    Emmanuel Villar
    Service de Nephrologie, dialyse et transplantation rénale, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, 165, Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Nephrol Ther 6:585-90. 2010
    ..All these epidemiological data help us to implement preventing measures and further researches in order to improve diabetes patient prognosis...
  3. ncbi [The NEPHRODIAB2 randomized trial]
    E Villar
    , Centre Hospitalier Lyon Sud, ,
    Nephrologie 24:317-9. 2003
  4. ncbi A multicentre study of registration on renal transplantation waiting list of the elderly and patients with type 2 diabetes
    Emmanuel Villar
    Department of Nephrology, Dialysis and Transplantation, Lyon Sud Hospital, Claude Bernard University, 165 Chemin du Grand Revoyet, 69495 Pierre Benite Cedex, France
    Nephrol Dial Transplant 19:207-14. 2004
    ....
  5. ncbi Effect of type 2 diabetes on mortality risk associated with end-stage kidney disease
    E Villar
    Australia and New Zealand Dialysis and Transplant Registry, Woodville, South Australia, Australia
    Diabetologia 52:2536-41. 2009
    ..Whether ESKD imparts the same excess in mortality risk for those with diabetes as it does for those without diabetes is unknown...
  6. ncbi Effect of age, gender, and diabetes on excess death in end-stage renal failure
    Emmanuel Villar
    Department of Nephrology, Dialysis and Transplantation, Lyon Sud Hospital, Pierre Benite, Lyon, France
    J Am Soc Nephrol 18:2125-34. 2007
    ..Older patients with ESRF experienced less excess mortality. ESRF cancels out women's survival advantage noted in the GP. SMR evolution in patients with DN was different from that in patients without DN...
  7. ncbi Poor prognosis of heart transplant patients with end-stage renal failure
    Emmanuel Villar
    Department of Nephrology, Dialysis and Transplantation, Hospices Civils de Lyon, Lyon Sud Hospital, Claude Bernard University, France
    Nephrol Dial Transplant 22:1383-9. 2007
    ..The aim of this study is to compare survival in heart transplant (HT) vs non-heart transplant (non-HT) patients starting dialysis...
  8. ncbi [Specificities of the methodology of survival analysis in dialysis patients]
    Emmanuel Villar
    Service de Nephrologie, dialyse et transplantation rénale, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, 165, Chemin du Grand Revoyet, 69495 Pierre Benite, France
    Nephrol Ther 4:553-61. 2008
    ..Our aim is to summarize the specificities of survival study methodology in dialysis patients using concrete examples in French cohorts...
  9. ncbi Multicenter study of the renal transplantation selection process: multivariate analysis
    E Villar
    Nephrology-Transplantation Unit, Lyon Sud Hospital, , France
    Transplant Proc 34:845-6. 2002
  10. ncbi The Impact of type 2 diabetes on mortality in end-stage renal disease patients differs between genders
    A Karamé
    Nephrology and Renal Transplantation, Lyon Sud Hospital, Hospices Civils de Lyon, Pierre Benite, France
    Nephron Clin Pract 112:c268-75. 2009
    ..We assessed the impact of type 2 diabetes (T2DM) on mortality in dialysis regarding its differential effect by gender using time-dependent analyses...
  11. ncbi Chronic renal failure and end-stage renal disease are associated with a high rate of mortality after heart transplantation
    A Hendawy
    Nephrology Transplantation Unit, Lyon Sud Hospital, Pierre Benite Cedex, France
    Transplant Proc 37:1352-4. 2005
    ..Death occurred in 18 HTP: 50% of patients with ESRD and 18.5% of patients with CRF-a 2.6 relative risk of of death in HTP patients with ESRD compared with HTP with CRF only (P < .01)...
  12. ncbi Incidences, treatments, outcomes, and sex effect on survival in patients with end-stage renal disease by diabetes status in Australia and New Zealand (1991 2005)
    Emmanuel Villar
    Australia and New Zealand Dialysis and Transplant Registry, Woodville, South Australia, Australia
    Diabetes Care 30:3070-6. 2007
    ....
  13. ncbi [Renal failure and neurogenic bladder]
    A Ruffion
    Service d urologie Lyon Sud, Centre Hospitalier Lyon Sud, UCBL Lyon 1, France
    Prog Urol 17:424-30. 2007
    ....
  14. ncbi [A tool to predict the resources necessary for the whole hemodialysis population]
    M Labeeuw
    Centre hospitalier Lyon Sud F 69495 Pierre Bénite
    Nephrologie 24:19-24. 2003
    ..The patients' records which take precedence in the future REIN should be modified in order to make possible a regular evaluation of the appropriateness of the resources allocated...
  15. ncbi [Epidemiology and etiology chronic renal insufficiency]
    C Pouteil-Noble
    Service de néphrologie Centre hospitalier Lyon Sud Pierre Bénite, 69495
    Rev Prat 51:365-71. 2001
    ....
  16. ncbi A Simple Modeling-free Method Provides Accurate Estimates of Sensitivity and Specificity of Longitudinal Disease Biomarkers
    Fabien Subtil
    CNRS, UMR 5558, Laboratoire de Biometrie et Biologie Evolutive, Equipe Biostatistique Santé, Pierre Benite, France
    Methods Inf Med 48:299-305. 2009
    ..To assess the time-dependent accuracy of a continuous longitudinal biomarker used as a test for early diagnosis or prognosis...
  17. ncbi Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares
    A Matrat
    Department of Immunology, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre Benite, France
    Lupus 20:28-34. 2011
    ..These data confirm that systematic detection of anti-C1q and anti-dsDNA aAbs is of interest for the follow-up in SLE patients with renal involvement...
  18. ncbi Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant
    Luc Frimat
    Department of Nephrology, University Hospital of Nancy, France
    Perit Dial Int 26:231-9. 2006
    ..We compared, in patients contraindicated for kidney transplant, outcomes between those patients who were only on hemodialysis (HD) and those who were given peritoneal dialysis (PD) as first renal replacement therapy (RRT)...
  19. ncbi Relative mortality risk in chronic kidney disease and end-stage renal disease: the effect of age, sex and diabetes
    Emmanuel Villar
    Nephrol Dial Transplant 23:1770-1. 2008
  20. ncbi Late referral and access to renal transplantation
    Emmanuel Villar
    Am J Kidney Dis 43:761; author reply 761-2. 2004
  21. ncbi Evaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemia
    Nathalie Thilly
    Department of Clinical Epidemiology and Evaluation, CEC CIE6 Inserm, University Hospital of Nancy, EA4003, Nancy University, Nancy, France
    Nephron Clin Pract 108:c67-74. 2008
    ..We used data from the French end-stage renal disease (ESRD) registry to investigate these determinants and the patients' anaemia status 1 year after starting dialysis...
  22. ncbi Anemia treatment and decline of renal function
    Emmanuel Villar
    Kidney Int 67:779; author reply 779-80. 2005